Page last updated: 2024-08-24

fluorodeoxyglucose f18 and Osteogenic Sarcoma

fluorodeoxyglucose f18 has been researched along with Osteogenic Sarcoma in 117 studies

Research

Studies (117)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (0.85)	18.7374
1990's	4 (3.42)	18.2507
2000's	31 (26.50)	29.6817
2010's	63 (53.85)	24.3611
2020's	18 (15.38)	2.80

Authors

Authors	Studies
Aparisi Gómez, MP; Bazzocchi, A; Fanti, S; Farina, A; Gasperini, C; Nanni, C	1
Cai, Z; Guo, W; Li, Y; Sun, K; Sun, X; Wang, Q; Wang, S; Xie, L; Xu, J	1
Chen, S; Gong, W; He, L; Liu, W; Zhang, C	1
Huang, Z; Liu, Y; Tang, W	1
Kessler, L	1
Adler, S; Basuli, F; Beck, JA; Cherukuri, A; Choyke, PL; Huang, S; Jagoda, EM; LeBlanc, AK; Olkowski, C; Phelps, TE; Ren, L; Roy, J; Ton, A; White, ME; Wong, K; Zhang, X	1
Wang, L; Wu, H; Ye, S	1
Dong, A; Fu, X; Liu, M; Zhu, Y; Zuo, C	1
Byun, BH; Jeong, SY; Kim, W; Kong, CB; Lim, I; Lim, SM; Song, WS; Woo, SK	1
Byun, BH; Cho, WH; Kim, W; Kong, CB; Lim, I; Lim, SM; Sheen, H; Song, WS; Woo, SK	1
Ahlawat, S; Cleary, MX; Fayad, LM	1
Chen, B; Feng, H; Li, C; Wang, S; Xie, J; Zhang, Y	1
Lan, X; Qin, C; Shao, F	1
Abraham, T; Chou, A; Doshi, H; Geller, D; Hoang, B; Loeb, D; Love, C; Moadel, R; Parkar, F; Tal, AL; Yang, R; Ye, K	1
Can, C; Gündoğan, C; Kömek, H	1
Engur, CO; Erdil, TY; Filizoglu, N; Ones, T; Turkoz, HK	1
Agrawal, A; Pereira, M; Prakash, A; Purandare, N; Puranik, AD; Rangarajan, V; Shah, S	1
Demirel, BB; Demirtaş Şenlik, S; Efetürk, H; Ergürhan İlhan, İ; Esen Akkaş, B; Fidan, AK; Öztürk, İ; Uçmak, G	1
Boye, K; Cesari, M; Guren, T; Hompland, I; Lobmaier, I; Longhi, A; Lorenz, S; Løndalen, AM; Meza-Zepeda, LA; Næss, S; Paioli, A; Palmerini, E; Pierini, M; Setola, E; Sundby Hall, K; Taksdal, I	1
Aryal, A; Gamanagatti, S; Khan, SA; Kumar, VS; Shamim, SA	1
Bailly, C; Bodet-Milin, C; Campion, L; Carlier, T; Kraeber-Bodere, F; Leforestier, R; Moreau, A; Thebaud, E	1
Gelfand, MJ; McCarville, MB; Sharp, SE; Shulkin, BL	1
Cho, SY; Daw, NC; Im, HJ; Navid, F; Shulkin, BL; Wu, H; Wu, J; Zhang, Y	1
Dong, A; Ran, P; Wang, Y; Wu, S; Zhang, Y	1
Guan, Z; Zhang, X	1
Luo, QY; Qiu, ZL; Shen, CT; Sun, ZK	1
Byun, BH; Cho, WH; Kim, BI; Koh, JS; Kong, CB; Lee, I; Lim, I; Lim, SM; Song, WS	1
Basques, K; Behzadi, AH; Carrino, JA; Gholamrezanezhad, A; Jadvar, H; Kosmas, C; Matcuk, GR; Patel, J; Raza, SI	1
Goni, V; Kumar, R; Mittal, BR; Parihar, AS; Sood, A; Vadi, SK	1
Tamam, C; Tamam, M	1
Alonso, MM; Collantes, M; Ecay, M; García-Velloso, MJ; Marrodán, L; Martínez-Vélez, N; Patiño-García, A; Peñuelas, I; Zalacain, M	1
Gillis, E; Wen, Z; Zhuang, H	1
Jiao, Y; Luo, QY; Qiu, Z; Ren, X; Shen, C; Song, H; Wang, Q; Wei, W; Yang, Q	1
Kairemo, K; Subbiah, V; Wang, WL	1
Dai, D; Li, YJ; Lin, SH; Wang, Q; Xu, WG	1
Byun, BH; Koh, JS; Kong, CB; Lim, SM; Yoo, JY	1
Byun, BH; Cho, WH; Choi, CW; Jeon, DG; Koh, JS; Kong, CB; Lee, SY; Lim, I; Lim, SM; Song, WS	1
Ametamey, SM; Arlt, MJ; Born, W; Brennecke, P; Campanile, C; Fischer, CR; Fuchs, B; Gvozdenovic, A; Honer, M; Krämer, SD; Müller, A; Sabile, AA; Schibli, R	1
Cao, Q; Chen, W; Dilsizian, V; Huebner, T; Lu, M	1
Byun, BH; Cho, WH; Choi, CW; Jeon, DG; Koh, JS; Kong, CB; Lee, SY; Lim, I; Lim, SM; Park, J; Seo, Y	1
Byun, BH; Cho, WH; Choi, CW; Jeon, DG; Kim, BI; Koh, JS; Kong, CB; Lee, SY; Lim, I; Lim, SM; Song, WS	2
Almeida, GS; Bacon, CM; Batey, MA; Blair, H; Dildey, P; Heidenreich, O; Hide, IG; Knizia, HK; Maxwell, RJ; Sharma, A; Vormoor, B; Vormoor, J; Wilson, I	1
Beale, T; Bomanji, J; Dileo, P; Frezza, AM; Jay, A; Kalavrezos, N; Strauss, SJ; Whelan, J	1
Choi, YY; Kim, JY; Yang, SO	1
Boerman, OC; Fleuren, ED; Flucke, UE; Franssen, GM; Houghton, PJ; Oyen, WJ; Roeffen, MH; van der Graaf, WT; Versleijen-Jonkers, YM	1
Boreham, DR; Lemon, JA; Phan, N; Taylor, K	1
Guo, FJ; Hao, Y; He, JP; Li, M; Wang, J	1
Aboagye, EO; Mann, D; Nguyen, QD; Patel, CB; Sala, R; Steinke, JH; Vilar, R	1
Chang, KJ; Cho, WH; Jeon, DG; Kong, CB; Lee, SY; Lim, I; Lim, SM	1
Baldari, S; Cistaro, A; Fox, J; Kuk, D; Quartuccio, N; Schöder, H; Wexler, LH	1
Koizumi, M; Koyama, M; Takahashi, S; Takeshima, N; Umayahara, K	1
Byun, BH; Cho, WH; Chung, SK; Jeon, DG; Kim, SH; Koh, JS; Kong, CB; Lee, SY; Lim, I; Lim, SM; Song, WS	1
Cai, L; Chen, Y; Huang, Z; Wu, J	1
Bentzen, SM; Bowen, SR; Bradshaw, TJ; Chappell, RJ; Deveau, MA; Forrest, LJ; Jeraj, R; Kubicek, L; White, P	1
Liu, B; Servaes, S; Yang, H; Zhuang, H	1
Dong, J; Li, J; Li, Z; Liu, F; Wang, B; Zhang, Q; Zhou, D; Zhu, D	1
Daryani, VM; Daw, NC; Dwek, JR; Fayad, LM; Glass, JO; Guo, J; Madewell, JE; Mao, S; McCarville, MB; Navid, F; Reddick, WE; Shulkin, BL; Stewart, CF; Wu, J	1
Altini, C; Ferrari, C; Niccoli Asabella, A; Rubini, G	1
Furuta, T; Johan, MP; Kubo, T; Ochi, M	1
Hou, Y; Jiang, L; Luan, L; Shi, H; Yun, H	1
Bishop, MW; Daw, NC; Hurley, C; Mao, S; McCarville, MB; Navid, F; Pappo, AS; Shulkin, BL; Wu, J	1
Chen, WW; Cheng, MF; Chou, YH; Ko, KY; Yen, RF	1
Cheon, GJ; Chung, JK; Im, HJ; Kang, KW; Lee, DS; Paeng, JC; Sarker, AK	1
Allen-Auerbach, MS; Benz, MR; Czernin, J; Eilber, FC; Evilevitch, V; Phelps, ME; Weber, WA	1
Li, W; Lin, N; Tian, M; Yang, D; Ye, Z; Zhan, H; Zhang, H; Zhao, C; Zhu, J	1
Arvanitis, C; Bendapudi, PK; Felsher, DW; Gambhir, SS; Tseng, JR	1
Fujimoto, T; Hamada, K; Hashimoto, N; Hatazawa, J; Inoue, A; Myoui, A; Tomita, Y; Yoshikawa, H	1
Anderson, PM; Bassett, RL; Costelloe, CM; Fitzgerald, NE; Harrell, RK; Lewis, VO; Macapinlac, HA; Madewell, JE; Marom, EM; Mawlawi, OR; Raymond, AK; Rohren, EM	1
Benz, MR; Czernin, J; Eilber, FC; Federman, N; Tap, WD; Tchekmedyian, N	1
Butrynski, JE; Conrad, EU; Eary, JF; Hawkins, DS; Schuetze, SM	1
Decouvelaere, AV; Duclos, ME; Dutour, A; Marec-Bérard, P; Monteil, J; Roualdes, O; Rousseau, R	1
Cheon, GJ; Cho, WH; Jeon, DG; Kim, MS; Koh, JS; Lee, JA; Lee, SY; Oh, DH; Shin, DS; Song, WS; Yoo, JY	1
Bassett, RL; Costelloe, CM; Fitzgerald, NE; Harrell, RK; Madewell, JE; Marom, EM; Mawlawi, OR; Nunez, RF; Raymond, AK	1
Dua, SG; Purandare, NC; Rangarajan, V; Shah, S; Sharma, AR	1
Eftekhari, F	1
Hickeson, M; Makis, W; Novales-Diaz, JA	1
Chen, YK; Hsieh, TC; Kao, CH; Liang, JA; Lin, YY; Sun, SS; Wang, CH; Wu, YC; Yen, KY	1
Agko, M; Aybar, PS; Chaudhuri, PK; Higgins, JA; Nazzal, M; Slam, K	1
Choong, PF; Di Bella, C; Gaston, LL; Hicks, RJ; Slavin, J	1
Boswell, W; Chang, D; Henderson, R; Ho, L; Seto, J; Wassef, H	1
Carpentier, P; Kolesnikov-Gauthier, H; Leblond, P; Rocourt, N	1
Im, HJ; Kang, HG; Kim, JH; Kim, SK; Kim, TS; Kwon, MM; Min, HS; Park, BK; Park, HJ; Park, SE; Park, SY; Yoon, JH	1
Bajpai, J; Bakhshi, S; Gamnagatti, S; Khan, SA; Kumar, R; Malhotra, A; Rastogi, S; Safaya, R; Sharma, MC; Sreenivas, V	1
Chezal, JM; Dauplat, MM; Gouin, F; Heymann, D; Miot-Noirault, E; Redini, F	1
Assayag, J; Azoulay, L; Brimo, F; Hickeson, M; Makis, W; Nahal, A; Rakheja, R; Skamene, S; Turcotte, R	1
Brach Del Prever, A; Cistaro, A; Fagioli, F; Fania, P; Gastaldo, L; Lopci, E	1
Aina, H; Bingshun, W; Daliu, M; Hongtao, L; Hui, Z; Shuier, Z; Xiaojin, W; Yang, Y; Yuanjue, S; Zan, S; Zhiyu, W	1
Carrasquillo, JA; Lim, R	1
Huellner, M; Kuttenberger, J; Merwald, M; Strobel, K; Zenklusen, HR	1
Byun, BH; Cho, WH; Choi, CW; Jeon, DG; Koh, JS; Kong, CB; Lee, SY; Lim, I; Lim, SM; Song, WS; Yoo, JY	1
Bruckner, JD; Conrad, EU; Eary, JF; Hawkins, DS; Rajendran, JG	1
Bielack, S; Flege, S; Franzius, C; Jürgens, H; Schober, O; Sciuk, J	1
Bergh, S; Boerner, AR; Brunkhorst, T; Gratz, FW; Knapp, WH; Otto, D	1
Franzius, C; Schober, O	1
Bohuslavizki, KH; Brenner, W; Eary, JF	1
Grünwald, F; Hamscho, N	1
Reiman, RE	1
Hamdan, A; Keller, A; Taylor, S; Toman, J	1
Connolly, LP; Connolly, SA; Davies, KJ	1
Chen, TH; Chen, WY; Hsu, HC; Hsu, YC; Huang, TL; Liu, RS	1
Al-Nahhas, A; Castellucci, P; Fanti, S; Farsad, M; Franchi, R; Gross, MD; Nanni, C; Rampin, L; Rubello, D	1
Baghel, NS; Basu, S; Nair, N	1
Jeon, DG; Kim, MS; Lee, SY; Sim, YS	1
Amthauer, H; Denecke, T; Furth, C; Hautzel, H; Henze, G; Misch, D; Plotkin, M; Ruf, J; Schönberger, S; Steffen, I; Stöver, B; Völker, T	1
Dobashi, Y; Sato, J; Takagishi, K; Watanabe, H; Yamaji, T; Yanagawa, T	1
Ahonen, A; Illukka, T; Johansson, R; Kiuru, A; Nordman, E; Paul, R; Roeda, D; Söderström, KO; Solin, O; Talvio, T	1
Altmann, A; Haberkorn, U; Kaick, GV; Klenner, T; Oberdorfer, F; Stöhr, M; Strauss, LG; Wallich, R	1
Ali, A; Alibazoglu, H; Green, A; Hollinger, EF; Lamonica, G	1
Abdel-Dayem, HM; Elzeftawy, HA; Naddaf, S; Zaher, AM	1
Brecht-Krauss, D; Delling, G; Guhlmann, A; Hartwig, E; Keppler, P; Kotzerke, J; Reske, SN; Sarkar, MR; Schulte, M; Werner, M	1
O'Doherty, MJ; Smith, MA	1
Fujii, H; Ide, M; Kubo, A; Mochizuki, Y; Nakahara, T; Shohtsu, A; Takahashi, W; Yasuda, S	1
Daldrup-Link, HE; Franzius, C; Jürgens, H; Schober, O; Sciuk, J	1
Brinkschmidt, C; Franzius, C; Jürgens, H; Schober, O; Sciuk, J	1
Bielack, S; Daldrup-Link, HE; Franzius, C; Jürgens, H; Rummeny, EJ; Schober, O; Sciuk, J	1
Bockisch, A; Franzius, C; Hillmann, A; Jürgens, H; Schober, O; Schulte, M; Winkelmann, W	1

Reviews

17 review(s) available for fluorodeoxyglucose f18 and Osteogenic Sarcoma

Article	Year
The Role of FDG-PET and Whole-Body MRI in High Grade Bone Sarcomas With Particular Focus on Osteosarcoma. Seminars in nuclear medicine, 2022, Volume: 52, Issue:5 Topics: Adolescent; Bone Neoplasms; Child; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Osteosarcoma; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoma; Young Adult	2022
Fibroblast Activation Protein Inhibitor (FAPI)-PET Imaging in Sarcoma. PET clinics, 2023, Volume: 18, Issue:3 Topics: Bone Neoplasms; Fibroblasts; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Osteosarcoma; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Sarcoma	2023
The Utility of 18FDG PET/CT Versus Bone Scan for Identification of Bone Metastases in a Pediatric Sarcoma Population and a Review of the Literature. Journal of pediatric hematology/oncology, 2021, 03-01, Volume: 43, Issue:2 Topics: Adolescent; Adult; Bone Neoplasms; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Osteosarcoma; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Sarcoma, Ewing; Young Adult	2021
PET/CT in the diagnosis and prognosis of osteosarcoma. Frontiers in bioscience (Landmark edition), 2018, 06-01, Volume: 23, Issue:11 Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Osteosarcoma; Positron Emission Tomography Computed Tomography; Prognosis; Sensitivity and Specificity; Treatment Outcome	2018
Applications of PET/CT and PET/MR Imaging in Primary Bone Malignancies. PET clinics, 2018, Volume: 13, Issue:4 Topics: Adult; Aged; Bone Neoplasms; Chondrosarcoma; Female; Fluorodeoxyglucose F18; Giant Cell Tumor of Bone; Humans; Lymphoma; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Multiple Myeloma; Osteosarcoma; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoma, Ewing; Young Adult	2018
PET/CT in benign and malignant musculoskeletal tumors and tumor-like conditions. Seminars in musculoskeletal radiology, 2014, Volume: 18, Issue:2 Topics: Adult; Biopsy; Bone Neoplasms; Chondrosarcoma; Fasciitis; Female; Fibrosarcoma; Fibrous Dysplasia of Bone; Fluorodeoxyglucose F18; Histiocytoma, Benign Fibrous; Humans; Lymphoma; Multiple Myeloma; Musculoskeletal Diseases; Neoplasm Staging; Osteosarcoma; Paraproteinemias; Plasmacytoma; Positron-Emission Tomography; Tomography, X-Ray Computed	2014
Tumor-to-background ratio to predict response to chemotherapy of osteosarcoma better than standard uptake values. Orthopaedic surgery, 2014, Volume: 6, Issue:2 Topics: Antineoplastic Agents; Bone Neoplasms; Chemotherapy, Adjuvant; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Osteosarcoma; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome	2014
Performance of Positron Emission Tomography and Positron Emission Tomography/Computed Tomography Using Fluorine-18-Fluorodeoxyglucose for the Diagnosis, Staging, and Recurrence Assessment of Bone Sarcoma: A Systematic Review and Meta-Analysis. Medicine, 2015, Volume: 94, Issue:36 Topics: Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Osteosarcoma; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed	2015
Prognostic significance of (18)F-FDG PET at diagnosis in patients with soft tissue sarcoma and bone sarcoma; systematic review and meta-analysis. European journal of cancer (Oxford, England : 1990), 2016, Volume: 58 Topics: Bone Neoplasms; Chi-Square Distribution; Fluorodeoxyglucose F18; Humans; Odds Ratio; Osteosarcoma; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Risk Factors; Sarcoma; Soft Tissue Neoplasms; Survival Analysis	2016
Utilization of positron emission tomography in the management of patients with sarcoma. Current opinion in oncology, 2009, Volume: 21, Issue:4 Topics: Bone Neoplasms; Dideoxynucleosides; Fluorodeoxyglucose F18; Humans; Neoplasm Staging; Osteosarcoma; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoma	2009
Imaging assessment of osteosarcoma in childhood and adolescence: diagnosis, staging, and evaluating response to chemotherapy. Cancer treatment and research, 2009, Volume: 152 Topics: Adolescent; Bone and Bones; Bone Neoplasms; Child; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Neoplasm Staging; Osteosarcoma; Radionuclide Imaging; Tomography, X-Ray Computed	2009
[Contribution of FDG-PET in the management of pediatric sarcomas in 2011]. Bulletin du cancer, 2011, Volume: 98, Issue:5 Topics: Bone Neoplasms; Child; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Recurrence, Local; Organ Specificity; Osteosarcoma; Positron-Emission Tomography; Practice Guidelines as Topic; Prognosis; Radiopharmaceuticals; Sarcoma	2011
18F-FDG positron emission tomography for the assessment of histological response to neoadjuvant chemotherapy in osteosarcomas: a meta-analysis. Surgical oncology, 2012, Volume: 21, Issue:4 Topics: Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Meta-Analysis as Topic; Neoadjuvant Therapy; Osteosarcoma; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals	2012
Assessment of therapy response by FDG PET in pediatric patients. The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), 2003, Volume: 47, Issue:1 Topics: Adolescent; Bone Neoplasms; Brain Neoplasms; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Humans; Infant; Infant, Newborn; Lymphoma; Male; Neoplasms; Osteosarcoma; Radiopharmaceuticals; Tomography, Emission-Computed; Treatment Outcome	2003
PET imaging of osteosarcoma. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2003, Volume: 44, Issue:6 Topics: Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Osteosarcoma; Radiopharmaceuticals; Tomography, Emission-Computed	2003
18F-FDG PET/CT fusion imaging in paediatric solid extracranial tumours. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2006, Volume: 60, Issue:9 Topics: Child; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lymphoma; Neoplasms; Neuroblastoma; Osteosarcoma; Positron-Emission Tomography; Tissue Distribution; Tomography, X-Ray Computed	2006
[Clinical value of positron emission tomography (PET) in the diagnosis of bone and soft tissue tumors. 3rd Interdisciplinary Consensus Conference "PET in Oncology": results of the Bone and Soft Tissue Study Group]. Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen, 2001, Volume: 72, Issue:9 Topics: Age Factors; Bone Neoplasms; Child; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Osteosarcoma; Prognosis; Radiopharmaceuticals; Sarcoma; Soft Tissue Neoplasms; Tomography, Emission-Computed	2001

Trials

11 trial(s) available for fluorodeoxyglucose f18 and Osteogenic Sarcoma

Article	Year
Pembrolizumab in advanced osteosarcoma: results of a single-arm, open-label, phase 2 trial. Cancer immunology, immunotherapy : CII, 2021, Volume: 70, Issue:9 Topics: Antibodies, Monoclonal, Humanized; B7-H1 Antigen; Biomarkers, Tumor; Bone Neoplasms; Combined Modality Therapy; Fluorodeoxyglucose F18; Gene Expression Profiling; Humans; Immune Checkpoint Inhibitors; Neoplasm Metastasis; Neoplasm Staging; Osteosarcoma; Positron Emission Tomography Computed Tomography; Treatment Outcome	2021
Combination of 18F-FDG PET/CT and diffusion-weighted MR imaging as a predictor of histologic response to neoadjuvant chemotherapy: preliminary results in osteosarcoma. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2013, Volume: 54, Issue:7 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Diffusion Magnetic Resonance Imaging; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Male; Methotrexate; Middle Aged; Multimodal Imaging; Neoadjuvant Therapy; Osteosarcoma; Pilot Projects; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed; Treatment Outcome; Young Adult	2013
Assessing vascular effects of adding bevacizumab to neoadjuvant chemotherapy in osteosarcoma using DCE-MRI. British journal of cancer, 2015, Nov-03, Volume: 113, Issue:9 Topics: Angiogenesis Inhibitors; Bevacizumab; Chemotherapy, Adjuvant; Child; Contrast Media; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Neoadjuvant Therapy; Osteosarcoma; Positron-Emission Tomography	2015
Response of osteogenic sarcoma to neoadjuvant therapy: evaluated by 18F-FDG-PET. Annals of nuclear medicine, 2008, Volume: 22, Issue:6 Topics: Adolescent; Adult; Antineoplastic Agents; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Female; Fluorodeoxyglucose F18; Humans; Male; Necrosis; Osteosarcoma; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Treatment Outcome	2008
Evaluation of chemotherapy response in osteosarcoma with FDG-PET. Annals of nuclear medicine, 2009, Volume: 23, Issue:1 Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Cisplatin; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Ifosfamide; Male; Methotrexate; Middle Aged; Osteosarcoma; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Treatment Outcome; Young Adult	2009
[F-18]-fluorodeoxy-D-glucose-positron emission tomography response is associated with outcome for extremity osteosarcoma in children and young adults. Cancer, 2009, Aug-01, Volume: 115, Issue:15 Topics: Adolescent; Adult; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Extremities; Fluorodeoxyglucose F18; Humans; Neoadjuvant Therapy; Osteosarcoma; Positron-Emission Tomography; Prognosis; Treatment Outcome; Young Adult	2009
Prediction model of chemotherapy response in osteosarcoma by 18F-FDG PET and MRI. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2009, Volume: 50, Issue:9 Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Computer Simulation; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Imaging, Three-Dimensional; Magnetic Resonance Imaging; Models, Biological; Osteosarcoma; Outcome Assessment, Health Care; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Treatment Outcome	2009
Prediction of tumour necrosis fractions using metabolic and volumetric 18F-FDG PET/CT indices, after one course and at the completion of neoadjuvant chemotherapy, in children and young adults with osteosarcoma. European journal of nuclear medicine and molecular imaging, 2012, Volume: 39, Issue:1 Topics: Adolescent; Adult; Bone Neoplasms; Child; Cohort Studies; Female; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Glucose Transporter Type 1; Glucose Transporter Type 3; Glycolysis; Humans; Magnetic Resonance Imaging; Male; Multimodal Imaging; Necrosis; Neoadjuvant Therapy; Osteosarcoma; Positron-Emission Tomography; ROC Curve; Tomography, X-Ray Computed; Treatment Outcome; Tumor Burden; Young Adult	2012
¹⁸F-FDG PET SUVmax as an indicator of histopathologic response after neoadjuvant chemotherapy in extremity osteosarcoma. European journal of nuclear medicine and molecular imaging, 2013, Volume: 40, Issue:5 Topics: Adolescent; Adult; Child; Extremities; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoadjuvant Therapy; Osteosarcoma; Positron-Emission Tomography; ROC Curve; Treatment Outcome; Young Adult	2013
Positron emission tomography for staging of pediatric sarcoma patients: results of a prospective multicenter trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2007, Dec-01, Volume: 25, Issue:34 Topics: Adolescent; Bone Neoplasms; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Humans; Infant; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Neoplasm Staging; Osteosarcoma; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Rhabdomyosarcoma; Sarcoma; Sarcoma, Ewing; Tomography, X-Ray Computed	2007
Evaluation of neoadjuvant therapy response of osteogenic sarcoma using FDG PET. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1999, Volume: 40, Issue:10 Topics: Adolescent; Adult; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Necrosis; Neoplasm Staging; Observer Variation; Osteosarcoma; Prospective Studies; Radiopharmaceuticals; Time Factors; Tomography, Emission-Computed	1999

Other Studies

89 other study(ies) available for fluorodeoxyglucose f18 and Osteogenic Sarcoma

Article	Year
An evaluation of the response to neoadjuvant chemotherapy for osteosarcoma of extremities: PERCIST versus RECIST 1.1 criteria after long-term follow-up. Annals of nuclear medicine, 2022, Volume: 36, Issue:6 Topics: Extremities; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Necrosis; Neoadjuvant Therapy; Osteosarcoma; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Response Evaluation Criteria in Solid Tumors; Retrospective Studies; Treatment Outcome	2022
Intense 68Ga-FAPI Uptake in a Patient With Myositis Ossificans: Mimicking Bone Malignancy. Clinical nuclear medicine, 2022, Jul-01, Volume: 47, Issue:7 Topics: Aged; Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Male; Myositis Ossificans; Osteosarcoma; Positron Emission Tomography Computed Tomography; Quinolines	2022
99mTc-MDP Bone Scan and 18F-FDG PET/CT Imaging of Primary Hepatic Osteosarcoma. Nuklearmedizin. Nuclear medicine, 2023, Volume: 62, Issue:4 Topics: Aged; Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Osteosarcoma; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Technetium Tc 99m Medronate	2023
Exploration of Imaging Biomarkers for Metabolically-Targeted Osteosarcoma Therapy in a Murine Xenograft Model. Cancer biotherapy & radiopharmaceuticals, 2023, Volume: 38, Issue:7 Topics: Animals; Biomarkers; Bone Neoplasms; Child; Disease Models, Animal; Fluorodeoxyglucose F18; Heterografts; Humans; Metformin; Mice; Osteosarcoma; Positron-Emission Tomography; Radiopharmaceuticals; Tissue Distribution	2023
A rare case of long venous tumor thrombi from the right femoral vein to the right ventricle visualized by [ European journal of nuclear medicine and molecular imaging, 2023, Volume: 51, Issue:1 Topics: Femoral Vein; Fluorodeoxyglucose F18; Heart Ventricles; Humans; Osteosarcoma; Positron Emission Tomography Computed Tomography	2023
Isolated Skull Metastasis With Unusual Spiculated Periosteal Reaction From Rectal Cancer Resembling Osteosarcoma on FDG PET/CT. Clinical nuclear medicine, 2023, Nov-01, Volume: 48, Issue:11 Topics: Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Osteosarcoma; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Rectal Neoplasms; Skull	2023
Prediction of Chemotherapy Response of Osteosarcoma Using Baseline Contrast media & molecular imaging, 2019, Volume: 2019 Topics: Area Under Curve; Drug Monitoring; Fluorodeoxyglucose F18; Humans; Machine Learning; Osteosarcoma; Positron-Emission Tomography; Predictive Value of Tests; Principal Component Analysis; Support Vector Machine	2019
Metastasis risk prediction model in osteosarcoma using metabolic imaging phenotypes: A multivariable radiomics model. PloS one, 2019, Volume: 14, Issue:11 Topics: Adult; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Neoplasm Metastasis; Osteosarcoma; Phenotype; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals	2019
Popliteal lymph nodes in patients with osteosarcoma: are they metastatic? Skeletal radiology, 2020, Volume: 49, Issue:11 Topics: Adolescent; Adult; Bone Neoplasms; Child; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Magnetic Resonance Imaging; Male; Osteosarcoma; Positron Emission Tomography Computed Tomography; Young Adult	2020
Differentiation of soft tissue and bone sarcomas from benign lesions utilizing BMC medical imaging, 2020, 07-25, Volume: 20, Issue:1 Topics: Adult; Aged; Bone Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Logistic Models; Male; Middle Aged; Multivariate Analysis; Osteosarcoma; Positron Emission Tomography Computed Tomography; Radiographic Image Interpretation, Computer-Assisted; Retrospective Studies; ROC Curve; Sarcoma; Soft Tissue Neoplasms; Tumor Burden	2020
Diffuse Increased 68Ga-DOTATATE But Unimpressive 18F-FDG Osseous Activity in a Patient With Rapid-Progressing Synchronous Multifocal Osteosarcoma. Clinical nuclear medicine, 2020, Volume: 45, Issue:10 Topics: Adolescent; Bone and Bones; Disease Progression; Fluorodeoxyglucose F18; Humans; Male; Organometallic Compounds; Osteosarcoma; Positron Emission Tomography Computed Tomography	2020
Is 68Ga-Prostate-Specific Membrane Antigen PET/CT Superior than 18F-FDG PET/CT for Evaluation of Metastatic Osteosarcoma? Clinical nuclear medicine, 2021, Apr-01, Volume: 46, Issue:4 Topics: Aged; Bone Neoplasms; Edetic Acid; Fluorodeoxyglucose F18; Gallium Isotopes; Gallium Radioisotopes; Humans; Male; Neoplasm Metastasis; Oligopeptides; Osteosarcoma; Positron Emission Tomography Computed Tomography; Sternum	2021
Calcified Adrenal Metastasis of High-Grade Osteosarcoma on FDG PET/CT. Clinical nuclear medicine, 2021, Mar-01, Volume: 46, Issue:3 Topics: Adolescent; Adrenal Gland Neoplasms; Bone Neoplasms; Calcinosis; Fluorodeoxyglucose F18; Humans; Male; Neoplasm Grading; Osteosarcoma; Positron Emission Tomography Computed Tomography	2021
Regorafenib-Associated Acute Pancreatitis Diagnosed on 18F-FDG PET/CT. Clinical nuclear medicine, 2021, May-01, Volume: 46, Issue:5 Topics: Fluorodeoxyglucose F18; Humans; Male; Osteosarcoma; Pancreatitis; Phenylurea Compounds; Positron Emission Tomography Computed Tomography; Pyridines; Young Adult	2021
The relation between staging fluorine-18 fluorodeoxyglucose positron emission tomog- raphy/computed tomography metabolic parameters and tumor necrosis rate in pediatric osteosarcoma patients Turkish journal of medical sciences, 2021, 06-28, Volume: 51, Issue:3 Topics: Bone Neoplasms; Child; Electrons; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Necrosis; Neoplasm Staging; Osteosarcoma; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies	2021
What Is the Comparative Ability of 18F-FDG PET/CT, 99mTc-MDP Skeletal Scintigraphy, and Whole-body MRI as a Staging Investigation to Detect Skeletal Metastases in Patients with Osteosarcoma and Ewing Sarcoma? Clinical orthopaedics and related research, 2021, 08-01, Volume: 479, Issue:8 Topics: Adolescent; Adult; Bone Neoplasms; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Neoplasm Metastasis; Neoplasm Staging; Osteosarcoma; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sarcoma, Ewing; Sensitivity and Specificity; Technetium Tc 99m Medronate; Whole Body Imaging; Young Adult	2021
Prognostic value of FDG-PET indices for the assessment of histological response to neoadjuvant chemotherapy and outcome in pediatric patients with Ewing sarcoma and osteosarcoma. PloS one, 2017, Volume: 12, Issue:8 Topics: Adolescent; Chemotherapy, Adjuvant; Child; Female; Fluorodeoxyglucose F18; Humans; Male; Neoplasm Metastasis; Osteosarcoma; Positron-Emission Tomography; Prognosis; Sarcoma, Ewing; Treatment Outcome	2017
FDG PET/CT appearance of local osteosarcoma recurrences in pediatric patients. Pediatric radiology, 2017, Volume: 47, Issue:13 Topics: Adolescent; Amputation, Surgical; Bone Neoplasms; Child; Female; Fluorodeoxyglucose F18; Humans; Leg; Limb Salvage; Male; Neoplasm Recurrence, Local; Osteosarcoma; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies	2017
Prognostic Value of Metabolic and Volumetric Parameters of FDG PET in Pediatric Osteosarcoma: A Hypothesis-generating Study. Radiology, 2018, Volume: 287, Issue:1 Topics: Adolescent; Adult; Child; Female; Fluorodeoxyglucose F18; Humans; Male; Osteosarcoma; Positron Emission Tomography Computed Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Tumor Burden; Young Adult	2018
Increased FDG Uptake in a Giant Bone Island Mimicking Malignancy. Clinical nuclear medicine, 2018, Volume: 43, Issue:6 Topics: Bone Neoplasms; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Osteosarcoma; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals	2018
99mTc-MDP Bone Scan and 18F-FDG PET/CT Imaging of Multiple Extraskeletal Osteosarcomas. Clinical nuclear medicine, 2018, Volume: 43, Issue:11 Topics: Bone and Bones; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Osteosarcoma; Positron Emission Tomography Computed Tomography; Technetium Tc 99m Medronate	2018
Comparison of 99mTc-methyl diphosphonate bone scintigraphy and 18F-fluorodeoxyglucose positron emission tomography/computed tomography to predict histologic response to neoadjuvant chemotherapy in patients with osteosarcoma. Medicine, 2018, Volume: 97, Issue:37 Topics: Adolescent; Adult; Area Under Curve; Bone Neoplasms; Chemotherapy, Adjuvant; Female; Fluorodeoxyglucose F18; Humans; Male; Neoadjuvant Therapy; Osteosarcoma; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Sensitivity and Specificity; Technetium Tc 99m Medronate; Treatment Outcome; Young Adult	2018
18F-FDG PET/CT in Isolated Primary Extraskeletal Osteosarcoma. Clinical nuclear medicine, 2018, Volume: 43, Issue:12 Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Osteosarcoma; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sarcoma	2018
Prognostic significance of maximum standardized uptake value on 18F-fluoro-2-deoxyglucose positron emission tomography/computed tomography in bone sarcomas. Eklem hastaliklari ve cerrahisi = Joint diseases & related surgery, 2018, Volume: 29, Issue:3 Topics: Adolescent; Adult; Aged; Bone Neoplasms; Child; Child, Preschool; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Osteosarcoma; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Young Adult	2018
Assessment of metabolic patterns and new antitumoral treatment in osteosarcoma xenograft models by [ BMC cancer, 2018, Nov-29, Volume: 18, Issue:1 Topics: Animals; Cell Line, Tumor; Disease Models, Animal; Energy Metabolism; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Male; Mice; Osteosarcoma; Positron-Emission Tomography; Radiopharmaceuticals	2018
Unusual Focal Muscle FDG Activity Related to Altered Biomechanics. Clinical nuclear medicine, 2019, Volume: 44, Issue:2 Topics: Biological Transport; Biomechanical Phenomena; Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Mechanical Phenomena; Muscles; Osteosarcoma; Positron Emission Tomography Computed Tomography; Young Adult	2019
Can pretreatment European radiology, 2019, Volume: 29, Issue:7 Topics: Adolescent; Adult; Aged; Bone Neoplasms; Chemotherapy, Adjuvant; Child; China; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Neoplasm Staging; Osteosarcoma; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Whole Body Imaging; Young Adult	2019
Comprehensive molecular imaging of malignant transformation of giant cell tumour of bone reveals diverse disease biology. BMJ case reports, 2019, Apr-23, Volume: 12, Issue:4 Topics: Adult; Bone Neoplasms; Cell Transformation, Neoplastic; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Giant Cell Tumor of Bone; Humans; Molecular Imaging; Neoplasm Metastasis; Osteosarcoma; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Rare Diseases; Sodium Fluoride; Technetium Tc 99m Medronate; Tomography, X-Ray Computed	2019
Primary pericardial osteosarcoma on FDG PET/CT. Clinical nuclear medicine, 2013, Volume: 38, Issue:8 Topics: Adult; Female; Fluorodeoxyglucose F18; Heart Neoplasms; Humans; Multimodal Imaging; Osteosarcoma; Positron-Emission Tomography; Tomography, X-Ray Computed	2013
(99m)Tc-MDP- and (18F)-FDG-avid florid reactive periostitis ossificans mimicking recurrent osteosarcoma. Clinical nuclear medicine, 2013, Volume: 38, Issue:6 Topics: Child; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Male; Neoplasm Recurrence, Local; Osteosarcoma; Periostitis; Radionuclide Imaging; Technetium Tc 99m Medronate	2013
Characterization of different osteosarcoma phenotypes by PET imaging in preclinical animal models. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2013, Volume: 54, Issue:8 Topics: Animals; Bone Neoplasms; Cell Line, Tumor; Disease Models, Animal; Drug Resistance, Neoplasm; Female; Fluorides; Fluorodeoxyglucose F18; Humans; Mice; Misonidazole; Osteoblasts; Osteoclasts; Osteosarcoma; Phenotype; Positron-Emission Tomography; Tibia	2013
18F-FDG PET/CT in a rare malignant extraskeletal osteosarcoma. Clinical nuclear medicine, 2013, Volume: 38, Issue:9 Topics: Adult; Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Male; Multimodal Imaging; Osteosarcoma; Positron-Emission Tomography; Tomography, X-Ray Computed	2013
Initial metabolic tumor volume measured by 18F-FDG PET/CT can predict the outcome of osteosarcoma of the extremities. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2013, Volume: 54, Issue:10 Topics: Adolescent; Adult; Child; Extremities; Female; Fluorodeoxyglucose F18; Humans; Male; Multimodal Imaging; Osteosarcoma; Positron-Emission Tomography; Prognosis; Retrospective Studies; Survival Analysis; Tomography, X-Ray Computed; Tumor Burden; Young Adult	2013
Comparison of (18)F-FDG PET/CT and (99 m)Tc-MDP bone scintigraphy for detection of bone metastasis in osteosarcoma. Skeletal radiology, 2013, Volume: 42, Issue:12 Topics: Adolescent; Adult; Bone Neoplasms; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Osteosarcoma; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Technetium Tc 99m Medronate; Tomography, X-Ray Computed; Treatment Outcome; Young Adult	2013
Development of a preclinical orthotopic xenograft model of ewing sarcoma and other human malignant bone disease using advanced in vivo imaging. PloS one, 2014, Volume: 9, Issue:1 Topics: Animals; Bone Neoplasms; Cell Line, Tumor; Diagnostic Imaging; Disease Models, Animal; Female; Fluorodeoxyglucose F18; Heterografts; Humans; Luminescent Measurements; Magnetic Resonance Imaging; Male; Mice; Osteolysis; Osteosarcoma; Positron-Emission Tomography; Sarcoma, Ewing; Tomography, X-Ray Computed	2014
Is [F-18]-fluorodeoxy-D-glucose positron emission tomography of value in the management of patients with craniofacial bone sarcomas undergoing neo-adjuvant treatment? BMC cancer, 2014, Jan-15, Volume: 14 Topics: Adult; Bone Neoplasms; Chemotherapy, Adjuvant; Disease Progression; Disease-Free Survival; Facial Bones; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Necrosis; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Osteosarcoma; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Skull; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Young Adult	2014
Early response monitoring to neoadjuvant chemotherapy in osteosarcoma using sequential ¹⁸F-FDG PET/CT and MRI. European journal of nuclear medicine and molecular imaging, 2014, Volume: 41, Issue:8 Topics: Adolescent; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Multimodal Imaging; Neoadjuvant Therapy; Osteosarcoma; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome; Young Adult	2014
Temsirolimus combined with cisplatin or bevacizumab is active in osteosarcoma models. International journal of cancer, 2014, Dec-15, Volume: 135, Issue:12 Topics: Angiogenesis Inhibitors; Animals; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Bone Neoplasms; Cell Line, Tumor; Cisplatin; Dideoxynucleosides; Female; Fluorodeoxyglucose F18; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Osteosarcoma; Positron-Emission Tomography; Protein Kinase Inhibitors; Sirolimus; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Xenograft Model Antitumor Assays	2014
Low-dose radiation from 18F-FDG PET does not increase cancer frequency or shorten latency but reduces kidney disease in cancer-prone Trp53+/- mice. Mutagenesis, 2014, Volume: 29, Issue:4 Topics: Animals; Dose-Response Relationship, Radiation; Fluorodeoxyglucose F18; Gamma Rays; Kidney Diseases; Lymphoma; Male; Mice; Neoplasms; Organ Specificity; Osteosarcoma; Positron-Emission Tomography; Survival Analysis; Tumor Suppressor Protein p53	2014
Phosphorylation status of thymidine kinase 1 following antiproliferative drug treatment mediates 3'-deoxy-3'-[18F]-fluorothymidine cellular retention. PloS one, 2014, Volume: 9, Issue:7 Topics: Antimetabolites; Antineoplastic Agents; Blotting, Western; Bone Neoplasms; Cell Cycle; Cell Proliferation; Colonic Neoplasms; Dideoxynucleosides; Fluorodeoxyglucose F18; Humans; Osteosarcoma; Phosphorylation; Protein Processing, Post-Translational; Radiopharmaceuticals; Thymidine Kinase; Tumor Cells, Cultured	2014
Usefulness of increased 18F-FDG uptake for detecting local recurrence in patients with extremity osteosarcoma treated with surgical resection and endoprosthetic replacement. Skeletal radiology, 2015, Volume: 44, Issue:4 Topics: Adolescent; Bone Neoplasms; Extremities; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Multimodal Imaging; Neoplasm Recurrence, Local; Osteosarcoma; Positron-Emission Tomography; Prostheses and Implants; Prosthesis Implantation; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed	2015
Pediatric bone sarcoma: diagnostic performance of ¹⁸F-FDG PET/CT versus conventional imaging for initial staging and follow-up. AJR. American journal of roentgenology, 2015, Volume: 204, Issue:1 Topics: Adolescent; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Multimodal Imaging; Neoplasm Staging; Observer Variation; Osteosarcoma; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed	2015
Radiation-induced osteosarcoma might mimic metastatic bone lesions: a case with bone scan and FDG PET/CT imaging. Clinical nuclear medicine, 2015, Volume: 40, Issue:5 Topics: Bone Neoplasms; Diagnostic Errors; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Neoplasms, Radiation-Induced; Osteosarcoma; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed	2015
Prediction of response to neoadjuvant chemotherapy in osteosarcoma using dual-phase (18)F-FDG PET/CT. European radiology, 2015, Volume: 25, Issue:7 Topics: Adolescent; Bone Neoplasms; Chemotherapy, Adjuvant; Female; Fluorodeoxyglucose F18; Humans; Male; Multimodal Imaging; Neoadjuvant Therapy; Osteosarcoma; Positron-Emission Tomography; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome; Young Adult	2015
Incidental Detection of Solitary Hepatic Metastasis by 99mTc-MDP and 18F-NaF PET/CT in a Patient With Osteosarcoma of the Tibia. Clinical nuclear medicine, 2015, Volume: 40, Issue:9 Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Liver Neoplasms; Multimodal Imaging; Osteosarcoma; Positron-Emission Tomography; Radiopharmaceuticals; Technetium Tc 99m Medronate; Tibia; Tomography, X-Ray Computed	2015
Molecular imaging biomarkers of resistance to radiation therapy for spontaneous nasal tumors in canines. International journal of radiation oncology, biology, physics, 2015, Mar-15, Volume: 91, Issue:4 Topics: Adenocarcinoma; Animals; Carcinoma, Squamous Cell; Chondrosarcoma; Coordination Complexes; Dog Diseases; Dogs; Dose Fractionation, Radiation; Female; Fluorodeoxyglucose F18; Male; Molecular Imaging; Multimodal Imaging; Nose Neoplasms; Organometallic Compounds; Osteosarcoma; Paranasal Sinus Neoplasms; Positron-Emission Tomography; Prognosis; Radiation Tolerance; Radiopharmaceuticals; Radiotherapy, Intensity-Modulated; Regression Analysis; Thiosemicarbazones; Thymidine; Tomography, X-Ray Computed; Tumor Burden	2015
Solitary Retroperitoneal Metastasis as the Initial Site of the Relapse of Osteosarcoma Revealed by FDG PET/CT. Clinical nuclear medicine, 2015, Volume: 40, Issue:11 Topics: Adolescent; Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Male; Multimodal Imaging; Osteosarcoma; Positron-Emission Tomography; Radiopharmaceuticals; Retroperitoneal Neoplasms; Tomography, X-Ray Computed	2015
A rare case of osteopetrosis mimicking osteosarcoma: 18F-FDG PET/CT findings in an unexpected diagnosis. Nuklearmedizin. Nuclear medicine, 2016, Volume: 55, Issue:1 Topics: Contrast Media; Diagnosis, Differential; Female; Femoral Neoplasms; Femur; Fluorodeoxyglucose F18; Humans; Osteopetrosis; Osteosarcoma; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals	2016
Extraosseous Osteosarcoma of the Liver Demonstrated on 18F-FDG PET/CT Imaging. Clinical nuclear medicine, 2016, Volume: 41, Issue:8 Topics: Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Middle Aged; Osteosarcoma; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals	2016
Comparison of (18) F-FDG-PET-CT and Bone Scintigraphy for Evaluation of Osseous Metastases in Newly Diagnosed and Recurrent Osteosarcoma. Pediatric blood & cancer, 2016, Volume: 63, Issue:8 Topics: Adolescent; Adult; Bone and Bones; Bone Neoplasms; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Humans; Male; Osteosarcoma; Positron Emission Tomography Computed Tomography; Radionuclide Imaging; Retrospective Studies; Young Adult	2016
18F-NaF PET/CT Images of Cardiac Metastasis From Osteosarcoma. Clinical nuclear medicine, 2016, Volume: 41, Issue:9 Topics: Adolescent; Bone Neoplasms; Fluorodeoxyglucose F18; Heart Neoplasms; Humans; Male; Multimodal Imaging; Neoplasm, Residual; Osteosarcoma; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals	2016
Plasmablastic lymphoma exclusively involving bones mimicking osteosarcoma in an immunocompetent patient: A case report. Medicine, 2016, Volume: 95, Issue:28 Topics: Adult; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Male; Mandibular Neoplasms; Osteosarcoma; Plasmablastic Lymphoma; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals	2016
Treatment monitoring by 18F-FDG PET/CT in patients with sarcomas: interobserver variability of quantitative parameters in treatment-induced changes in histopathologically responding and nonresponding tumors. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2008, Volume: 49, Issue:7 Topics: Adult; Aged; Aged, 80 and over; Bone Neoplasms; Chemotherapy, Adjuvant; Female; Fluorodeoxyglucose F18; Glucose; Humans; Image Interpretation, Computer-Assisted; Male; Middle Aged; Neoadjuvant Therapy; Observer Variation; Osteosarcoma; Positron-Emission Tomography; Radiopharmaceuticals; Soft Tissue Neoplasms	2008
(18)F and (18)FDG PET imaging of osteosarcoma to non-invasively monitor in situ changes in cellular proliferation and bone differentiation upon MYC inactivation. Cancer biology & therapy, 2008, Volume: 7, Issue:12 Topics: Animals; Bone and Bones; Bone Development; Bone Neoplasms; Cell Differentiation; Cell Division; Disease Models, Animal; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gene Silencing; Genes, myc; Humans; Mice; Mice, Transgenic; Neoplasm Invasiveness; Osteosarcoma; Positron-Emission Tomography; Radiography	2008
18F-FDG PET/CT as an indicator of progression-free and overall survival in osteosarcoma. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2009, Volume: 50, Issue:3 Topics: Adolescent; Adult; Aged; Bone Neoplasms; Child; Disease-Free Survival; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoadjuvant Therapy; Osteosarcoma; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed; Treatment Outcome; Young Adult	2009
18F-FDG PET SUVmax correlates with osteosarcoma histologic response to neoadjuvant chemotherapy: preclinical evaluation in an orthotopic rat model. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2009, Volume: 50, Issue:9 Topics: Animals; Antineoplastic Agents; Bone Neoplasms; Chemotherapy, Adjuvant; Disease Models, Animal; Drug Evaluation, Preclinical; Fluorodeoxyglucose F18; Humans; Metabolic Clearance Rate; Neoadjuvant Therapy; Osteosarcoma; Positron-Emission Tomography; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Statistics as Topic; Treatment Outcome	2009
Tumor necrosis in osteosarcoma: inclusion of the point of greatest metabolic activity from F-18 FDG PET/CT in the histopathologic analysis. Skeletal radiology, 2010, Volume: 39, Issue:2 Topics: Bone Neoplasms; Fluorodeoxyglucose F18; Image Interpretation, Computer-Assisted; Necrosis; Osteosarcoma; Positron-Emission Tomography; Prevalence; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Risk Factors; Sensitivity and Specificity; Survival Analysis; Survival Rate; Texas; Tomography, X-Ray Computed	2010
Pulmonary artery and femoral vein tumour thromboembolism in a patient with osteogenic sarcoma demonstrated by FDG PET/CT. European journal of nuclear medicine and molecular imaging, 2010, Volume: 37, Issue:3 Topics: Adult; Bone Neoplasms; Femoral Vein; Fluorodeoxyglucose F18; Humans; Male; Neoplastic Cells, Circulating; Osteosarcoma; Positron-Emission Tomography; Pulmonary Artery; Tomography, X-Ray Computed	2010
Primary thyroid osteosarcoma: staging and evaluation of response to therapy with F-18 FDG PET-CT. Clinical nuclear medicine, 2010, Volume: 35, Issue:7 Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Neoplasm Staging; Osteosarcoma; Positron-Emission Tomography; Thyroid Neoplasms; Tomography, X-Ray Computed	2010
Exposing the evil in the dark: the usefulness of delayed-phase FDG PET scan to enhance the detectability of tiny residual skull base osteosarcoma initially concealed by adjacent high physiological brain activity. Clinical nuclear medicine, 2010, Volume: 35, Issue:8 Topics: Brain; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm, Residual; Osteosarcoma; Positron-Emission Tomography; Sensitivity and Specificity; Skull Base Neoplasms; Time Factors; Tomography, X-Ray Computed	2010
Retroperitoneal extraskeletal osteosarcomas. The American surgeon, 2010, Volume: 76, Issue:12 Topics: Aged; Bone Neoplasms; CA-125 Antigen; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Osteosarcoma; Positron-Emission Tomography; Radiopharmaceuticals; Retroperitoneal Neoplasms; Sensitivity and Specificity; Tomography, X-Ray Computed	2010
18F-FDG PET response to neoadjuvant chemotherapy for Ewing sarcoma and osteosarcoma are different. Skeletal radiology, 2011, Volume: 40, Issue:8 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoadjuvant Therapy; Osteosarcoma; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sarcoma, Ewing; Treatment Outcome	2011
Liposarcoma of the retroperitoneum with dedifferentiation to osteosarcoma: a case report. Clinical nuclear medicine, 2011, Volume: 36, Issue:5 Topics: Fluorodeoxyglucose F18; Humans; Liposarcoma; Male; Middle Aged; Osteosarcoma; Positron-Emission Tomography; Retroperitoneal Space; Tomography, X-Ray Computed	2011
Prediction of chemotherapy response by PET-CT in osteosarcoma: correlation with histologic necrosis. Journal of pediatric hematology/oncology, 2011, Volume: 33, Issue:7 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Necrosis; Neoadjuvant Therapy; Osteosarcoma; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome; Young Adult	2011
Relevance of the POS-1 orthotopic model as an "imaging model" for in vivo and simultaneous monitoring of tumor proliferation and bone remodeling in osteosarcoma. Cancer biotherapy & radiopharmaceuticals, 2012, Volume: 27, Issue:1 Topics: Animals; Bone Neoplasms; Bone Remodeling; Cell Growth Processes; Fluorodeoxyglucose F18; Male; Mice; Mice, Inbred C3H; Osteosarcoma; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Medronate	2012
Correlating metabolic activity on 18F-FDG PET/CT with histopathologic characteristics of osseous and soft-tissue sarcomas: a retrospective review of 136 patients. AJR. American journal of roentgenology, 2012, Volume: 198, Issue:6 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Necrosis; Neoplasm Staging; Osteosarcoma; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sarcoma; Statistics, Nonparametric; Tomography, X-Ray Computed	2012
The role of 18F-FDG PET/CT in the metabolic characterization of lung nodules in pediatric patients with bone sarcoma. Pediatric blood & cancer, 2012, Dec-15, Volume: 59, Issue:7 Topics: Adolescent; Adult; Bone Neoplasms; Child; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Multimodal Imaging; Osteosarcoma; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sarcoma, Ewing; Sensitivity and Specificity; Tomography, X-Ray Computed; Young Adult	2012
18F-FDG uptake in metaphyseal growth arrest lines: a case study. Clinical nuclear medicine, 2012, Volume: 37, Issue:10 Topics: Biological Transport; Child; Fluorodeoxyglucose F18; Growth Plate; Humans; Male; Osteosarcoma; Positron-Emission Tomography	2012
Osteoblastoma of the mandible mimicking osteosarcoma in FDG PET/CT imaging. Clinical nuclear medicine, 2013, Volume: 38, Issue:2 Topics: Adult; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Mandible; Mandibular Neoplasms; Multimodal Imaging; Osteoblastoma; Osteosarcoma; Positron-Emission Tomography; Tomography, X-Ray Computed	2013
Evaluation of chemotherapy response in pediatric bone sarcomas by [F-18]-fluorodeoxy-D-glucose positron emission tomography. Cancer, 2002, Jun-15, Volume: 94, Issue:12 Topics: Adolescent; Adult; Bone Neoplasms; Child; Female; Fluorodeoxyglucose F18; Humans; Male; Osteosarcoma; Tomography, Emission-Computed	2002
Prognostic significance of (18)F-FDG and (99m)Tc-methylene diphosphonate uptake in primary osteosarcoma. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2002, Volume: 43, Issue:8 Topics: Adolescent; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glucose; Humans; Male; Osteosarcoma; Prognosis; Radiopharmaceuticals; Retrospective Studies; Survival Rate; Technetium Tc 99m Medronate; Time Factors; Tomography, Emission-Computed	2002
Pretherapeutic assessment of tumour metabolism using a dual tracer PET technique. European journal of nuclear medicine and molecular imaging, 2002, Volume: 29, Issue:10 Topics: Adolescent; Bone Neoplasms; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Mediastinal Neoplasms; Osteosarcoma; Radiopharmaceuticals; Sodium Fluoride; Soft Tissue Neoplasms; Tomography, Emission-Computed	2002
Prognosis of primary osteosarcoma. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2003, Volume: 44, Issue:6 Topics: Adolescent; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glucose; Humans; Male; Osteosarcoma; Prognosis; Radiopharmaceuticals; Retrospective Studies; Survival Rate; Technetium Tc 99m Medronate; Time Factors; Tomography, Emission-Computed	2003
PET tracers for osteosarcoma. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2004, Volume: 45, Issue:8 Topics: Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Osteosarcoma; Radioisotopes; Radiopharmaceuticals; Tomography, Emission-Computed	2004
Nuclear imaging of an extraskeletal retroperitoneal osteosarcoma: respective contribution of 18FDG-PET and (99m)Tc oxidronate (2005:1b). European radiology, 2005, Volume: 15, Issue:4 Topics: Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Osteosarcoma; Positron-Emission Tomography; Radiopharmaceuticals; Retroperitoneal Neoplasms; Technetium Tc 99m Medronate	2005
Avulsive cortical irregularity and F-18 FDG PET. Clinical nuclear medicine, 2006, Volume: 31, Issue:2 Topics: Child; Diagnosis, Differential; False Positive Reactions; Femoral Neoplasms; Femur; Fluorodeoxyglucose F18; Humans; Male; Osteosarcoma; Positron-Emission Tomography; Radiopharmaceuticals	2006
Comparison between F-18-FDG positron emission tomography and histology for the assessment of tumor necrosis rates in primary osteosarcoma. Journal of the Chinese Medical Association : JCMA, 2006, Volume: 69, Issue:8 Topics: Adolescent; Adult; Bone Neoplasms; Child, Preschool; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Necrosis; Osteosarcoma; Positron-Emission Tomography; Prospective Studies	2006
A hypermetabolic abdominal focus in a case of osteogenic sarcoma on 18FDG-PET: in vivo insight into the gravid myometrial metabolism pattern. The British journal of radiology, 2007, Volume: 80, Issue:958 Topics: Adult; Female; Femoral Neoplasms; Fluorodeoxyglucose F18; Humans; Myometrium; Osteosarcoma; Positron-Emission Tomography; Pregnancy; Pregnancy Complications, Neoplastic; Radiopharmaceuticals	2007
Occult thyroid carcinoma detected by FDG-PET scan in elderly osteosarcoma patients: report of two cases. Annals of nuclear medicine, 2007, Volume: 21, Issue:9 Topics: Bone Neoplasms; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Incidental Findings; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Multiple Primary; Osteosarcoma; Osteotomy; Positron-Emission Tomography; Radiopharmaceuticals; Thyroid Neoplasms; Thyroidectomy	2007
Prognostic significance of 18F-FDG uptake in primary osteosarcoma after but not before chemotherapy: a possible association with autocrine motility factor/phosphoglucose isomerase expression. Clinical & experimental metastasis, 2008, Volume: 25, Issue:4 Topics: Adolescent; Adult; Bone Neoplasms; Child; Female; Fluorodeoxyglucose F18; Glucose-6-Phosphate Isomerase; Humans; Immunohistochemistry; Male; Middle Aged; Osteosarcoma; Positron-Emission Tomography; Prognosis	2008
Imaging of canine cancers with 18F-2-fluoro-2-deoxy-D-glucose (FDG) suggests further applications for cancer imaging in man. Nuclear medicine communications, 1984, Volume: 5, Issue:10 Topics: Animals; Deoxy Sugars; Deoxyglucose; Dog Diseases; Dogs; Female; Fluorine; Fluorodeoxyglucose F18; Male; Mammary Glands, Animal; Neoplasms; Osteosarcoma; Radioisotopes; Radionuclide Imaging	1984
Metabolic and transcriptional changes in osteosarcoma cells treated with chemotherapeutic drugs. Nuclear medicine and biology, 1994, Volume: 21, Issue:6 Topics: Animals; Antineoplastic Agents; Bone Neoplasms; Cisplatin; Deoxyglucose; Flow Cytometry; Fluorodeoxyglucose F18; Lung Neoplasms; Organophosphorus Compounds; Organoplatinum Compounds; Osteosarcoma; Rats; Thymidine; Transcription, Genetic	1994
Hematopoietic cytokine-mediated FDG uptake simulates the appearance of diffuse metastatic disease on whole-body PET imaging. Clinical nuclear medicine, 1998, Volume: 23, Issue:2 Topics: Adolescent; Adult; Bone Marrow; Bone Marrow Neoplasms; Female; Fluorodeoxyglucose F18; Granulocyte Colony-Stimulating Factor; Humans; Male; Middle Aged; Neoplasms; Osteosarcoma; Radiopharmaceuticals; Retrospective Studies; Tomography, Emission-Computed	1998
The "backpack sign": abnormal findings on fluorine-18 fluorodeoxyglucose imaging. Clinical nuclear medicine, 1999, Volume: 24, Issue:7 Topics: Adult; Cervical Vertebrae; Fluorodeoxyglucose F18; Humans; Male; Neck Muscles; Osteosarcoma; Spinal Neoplasms; Tomography, Emission-Computed	1999
Positron emission tomography and the orthopaedic surgeon. The Journal of bone and joint surgery. British volume, 2000, Volume: 82, Issue:3 Topics: Bone Neoplasms; Contrast Media; Fluorodeoxyglucose F18; Humans; Osteosarcoma; Prognosis; Sarcoma; Soft Tissue Neoplasms; Tomography, Emission-Computed	2000
Increased fluorodeoxyglucose uptake in a calf opposite to a leg with osteosarcoma after operation. Clinical nuclear medicine, 2000, Volume: 25, Issue:7 Topics: Adult; Bone Neoplasms; Fibula; Fluorodeoxyglucose F18; Humans; Male; Muscle, Skeletal; Osteosarcoma; Tibia; Tomography, Emission-Computed	2000
FDG-PET for detection of osseous metastases from malignant primary bone tumours: comparison with bone scintigraphy. European journal of nuclear medicine, 2000, Volume: 27, Issue:9 Topics: Adolescent; Adult; Bone and Bones; Bone Neoplasms; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Osteosarcoma; Retrospective Studies; Sarcoma, Ewing; Tomography, Emission-Computed	2000
Evaluation of chemotherapy response in primary bone tumors with F-18 FDG positron emission tomography compared with histologically assessed tumor necrosis. Clinical nuclear medicine, 2000, Volume: 25, Issue:11 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Humans; Male; Necrosis; Osteosarcoma; Radiopharmaceuticals; Retrospective Studies; Sarcoma, Ewing; Tomography, Emission-Computed	2000
FDG-PET for detection of pulmonary metastases from malignant primary bone tumors: comparison with spiral CT. Annals of oncology : official journal of the European Society for Medical Oncology, 2001, Volume: 12, Issue:4 Topics: Adolescent; Adult; Bone and Bones; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Osteosarcoma; Radiography, Thoracic; Radiopharmaceuticals; Retrospective Studies; Sarcoma, Ewing; Sensitivity and Specificity; Tomography, Emission-Computed	2001